Comparative effects of scopolamine and phencynonate on organophosphorus nerve agent-induced seizure activity, neuropathology and lethality

References

• Anderson DR, Gennings C, Carter WH, Harris LW, Lennox WJ, Bowersox SL, Solana RP. 1994. Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs. Fundam Appl Toxicol. 22:588–593.
   PubMedGoogle Scholar
• Atchison CR, Sheridan RE, Duniho SM, Shih TM. 2004. Development of a guinea pig model for low-dose, long-term exposure to organophosphorus nerve agents. Toxicol Mech Methods.14:183–194.
   PubMed Web of Science ®Google Scholar
• Berry WK, Davies DR. 1970. The use of carbamates and atropine in the protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem Pharmacol. 19:927–934.
   PubMed Web of Science ®Google Scholar
• Braitman DJ, Sparenborg S. 1989. MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res Bull. 23:145–148.
   PubMed Web of Science ®Google Scholar
• Brimblecombe RW, Green DM, Stratton JA, Thompson PB. 1970. The protective actions of some anticholinergic drugs in sarin poisoning. Br J Pharmacol. 39:822–830.
   PubMed Web of Science ®Google Scholar
• Capacio BR, Lawrence RJ, Zydel F, di Targiani RC, Smith JR, Johnson EA, McDonough JH, Shih TM, Koplovitz I. 2014. Pharmacokinetics of scopolamine following intramuscular administration to guinea pigs. In: The pharmacokinetics of scopolamine in human and animal studies. U.S. Army Medical Research Institute of Chemical Defense Technical Report; p. 17--18.
   Google Scholar
• Capacio BR, Shih TM. 1991. Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia. 32:604–615.
   PubMed Web of Science ®Google Scholar
• Clissold SP, Heel RC. 1985. Transdermal hyoscine (scopolamine). A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs. 29:189–207.
   PubMed Web of Science ®Google Scholar
• Coleman IW, Little PE, Bannard RA. 1962. Cholinolytics in the treatment of anticholinesterase poisoning. I. The effectiveness of certain cholinolytics in combination with an oxime for treatment of sarin poisoning. Can J Biochem Physiol. 40:815–826.
   PubMedGoogle Scholar
• Coleman IW, Patton GE, Bannard RA. 1968. Cholinolytics in the treatment of anticholinesterase poisoning. V. The effectiveness of parpanit with oximes in the treatment of organophosphorus poisoning. Can J Physiol Pharmacol. 46:109–117.
   PubMed Web of Science ®Google Scholar
• Dai JG, Liu CG, Yu LSH. 1997. Antimotion sickness effect of phencynonate hydrochloride in man. Chin J Aerosp Med 8:10–14.
   Google Scholar
• Dirnhuber P, French MC, Green DM, Leadbeater L, Stratton JA. 1979. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J Pharm Pharmacol. 31:295–299.
   PubMed Web of Science ®Google Scholar
• Ebert U, Grossmann M, Oertel R, Gramatte T, Kirch W. 2001. Pharmacokinetic-pharmacodynamic modeling of the electroencephalogram effects of scopolamine in healthy volunteers. J Clin Pharmacol. 41:51–60.
   PubMed Web of Science ®Google Scholar
• Figueiredo TH, Aroniadou-Anderjaska V, Qashu F, Apland JP, Pidoplichko V, Stevens D, Ferrara TM, Braga MF. 2011. Neuroprotective efficacy of caramiphen against soman and mechanisms of its action. Br J Pharmacol. 164:1495–1505.
   PubMed Web of Science ®Google Scholar
• Ge Z, Yang M, Wang Y, Shan L, Gao C. 2015. Preparation and evaluation of orally disintegrating tablets of taste masked phencynonate HCl using ion-exchange resin. Drug Dev Ind Pharm. 41:934–941.
   PubMed Web of Science ®Google Scholar
• Harris LW, Gennings C, Carter WH, Anderson DR, Lennox WJ, Bowersox SL, Solana RP. 1994. Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs. Drug Chem Toxicol. 17:35–50.
   PubMed Web of Science ®Google Scholar
• Hayward IJ, Wall HG, Jaax NK, Wade JV, Marlow DD, Nold JB. 1990. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J Neurol Sci. 98:99–106.
   PubMed Web of Science ®Google Scholar
• Inns RH, Leadbeater L. 1983. The efficacy of bispyridinium derivatives in the treatment of organophosphonate poisoning in the guinea-pig. J Pharm Pharmacol. 35:427–433.
   PubMed Web of Science ®Google Scholar
• Jovic R, Milosevic M. 1970. Effective doses of some cholinolytics in the treatment of anticholinesterase poisoning. Eur J Pharmacol. 12:85–93.
   PubMed Web of Science ®Google Scholar
• Ketchum JS, Sidell FR, Crowell EB, Jr., Aghajanian GK, Hayes AH. Jr. 1973. Atropine, scopolamine, and ditran: comparative pharmacology and antagonists in man. Psychopharmacologia. 28:121–145.
   PubMed Web of Science ®Google Scholar
• Koplovitz I, Schulz S. 2010. Perspectives on the use of scopolamine as an adjunct treatment to enhance survival following organophosphorus nerve agent poisoning. Mil Med. 175:878–882.
   PubMed Web of Science ®Google Scholar
• Koplovitz I, Schulz S, Shutz M, Railer R, Macalalag R, Schons M, McDonough J. 2001. Combination anticonvulsant treatment of soman-induced seizures. J Appl Toxicol. 21 Suppl 1:S53–S55.
   PubMedGoogle Scholar
• Kou Y, Liu Y, Xue M, Xu Y, Liu H, Ruan J, Liu K. 2008. Comparative pharmacokinetics and distribution kinetics in brain of phencynonate enantiomers in rats. Int J Pharm. 353:88–94.
   PubMedGoogle Scholar
• Lallement G, Carpentier P, Collet A, Baubichon D, Pernot-Marino I, Blanchet G. 1992. Extracellular acetylcholine changes in rat limbic structures during soman-induced seizures. Neurotoxicology. 13:557–567.
   PubMed Web of Science ®Google Scholar
• Lallement G, Carpentier P, Collet A, Pernot-Marino I, Baubichon D, Blanchet G. 1991a. Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 563:234–240.
   PubMed Web of Science ®Google Scholar
• Lallement G, Carpentier P, Collet A, Pernot-Marino I, Baubichon D, Sentenac-Roumanou H, Blanchet G. 1991b. Involvement of glutamatergic system of amygdala in generalized seizures induced by soman: comparison with the hippocampus. C R Acad Sci III. 313:421–426.
   PubMed Web of Science ®Google Scholar
• Lallement G, Carpentier P, Pernot-Marino I, Baubichon D, Collet A, Blanchet G. 1991c. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: an autoradiographic study. Neurotoxicology. 12:655–664.
   PubMed Web of Science ®Google Scholar
• Lallement G, Clarencon D, Brochier G, Baubichon D, Galonnier M, Blanchet G, Mestries JC. 1997. Efficacy of atropine/pralidoxime/diazepam or atropine/HI-6/prodiazepam in primates intoxicated by soman. Pharmacol Biochem Behav. 56:325–332.
   PubMed Web of Science ®Google Scholar
• Lemercier G, Carpentier P, Sentenac-Roumanou H, Morelis P. 1983. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. 61:123–129.
   PubMed Web of Science ®Google Scholar
• Lennox WJ, Harris LW, Talbot BG, Anderson DR. 1985. Relationship between reversible acetylcholinesterase inhibition and efficacy against soman lethality. Life Sci. 37:793--798.
   Google Scholar
• Maxwell DM, Brecht KM, O'Neill BL. 1987. The effect of carboxylesterase inhibition on interspecies differences in soman toxicity. Toxicol Lett. 39:35–42.
   PubMed Web of Science ®Google Scholar
• McDonough JH, McMonagle JD, Shih TM. 2010. Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs. Drug Chem Toxicol. 33:279–283.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Jr, Shih TM. 1993. Pharmacological modulation of soman-induced seizures. Neurosci Biobehav Rev. 17:203–215.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Jr, Shih TM. 1995. A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs. Pharmacol Biochem Behav. 51:249–253.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Jr, Shih TM. 1997. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci Biobehav Rev. 21:559–579.
   PubMed Web of Science ®Google Scholar
• McDonough JH, Jr., Zoeffel LD, McMonagle J, Copeland TL, Smith CD, Shih TM. 1999. Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs. Epilepsy Res. 38:1–14.
   Web of Science ®Google Scholar
• McLeod CG. Jr. 1985. Pathology of nerve agents: perspectives on medical management. Fundam Appl Toxicol. 5:S10–S16.
   PubMedGoogle Scholar
• Meshulam Y, Cohen G, Chapman S, Alkalai D, Levy A. 2001. Prophylaxis against organophosphate poisoning by sustained release of scopolamine and physostigmine. J Appl Toxicol. 21 Suppl 1:S75–S78.
   PubMed Web of Science ®Google Scholar
• Moore DH, Clifford CB, Crawford IT, Cole GM, Baggett JM. 1995. Review of nerve agent inhibitors and reactivators of acetylcholinesterase. In: Quinn DM, Balasubramanian AS, Doctor BP, Taylor P, editors. Enzymes of the cholinesterase family. Boston: Springer; p. 297--304.
   Google Scholar
• Muir KW, Lees KR. 1995. Clinical experience with excitatory amino acid antagonist drugs. Stroke. 26:503–513.
   PubMed Web of Science ®Google Scholar
• Nachum Z, Shupak A, Gordon CR. 2006. Transdermal scopolamine for prevention of motion sickness: clinical pharmacokinetics and therapeutic applications. Clin Pharmacokinet. 45:543–566.
   PubMed Web of Science ®Google Scholar
• O'Donnell JC, McDonough JH, Shih TM. 2011. In vivo microdialysis and electroencephalographic activity in freely moving guinea pigs exposed to organophosphorus nerve agents sarin and VX: analysis of acetylcholine and glutamate. Arch Toxicol. 85:1607–1616.
   PubMed Web of Science ®Google Scholar
• Olney JW, Price MT, Labruyere J, Salles KS, Frierdich G, Mueller M, Silverman E. 1987. Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur J Pharmacol. 142:319–320.
   PubMed Web of Science ®Google Scholar
• Petras JM. 1981. Soman neurotoxicity. Fundam Appl Toxicol. 1:242.
   PubMedGoogle Scholar
• Philippens IH, Melchers BP, de Groot DM, Wolthuis OL. 1992. Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol Biochem Behav. 42:711–719.
   PubMed Web of Science ®Google Scholar
• Philippens IH, Melchers BP, Olivier B, Bruijnzeel PL. 2000. Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs. Pharmacol Biochem Behav. 65:175–182.
   PubMed Web of Science ®Google Scholar
• Raffaele K, Hughey D, Wenk G, Olton D, Modrow H, McDonough J. 1987. Long-term behavioral changes in rats following organophosphonate exposure. Pharmacol Biochem Behav. 27:407–412.
   PubMed Web of Science ®Google Scholar
• Reddy SD, Reddy DS. 2015. Midazolam as an anticonvulsant antidote for organophosphate intoxication-a pharmacotherapeutic appraisal. Epilepsia. 56:813–821.
   PubMed Web of Science ®Google Scholar
• Renner UD, Oertel R, Kirch W. 2005. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Ther Drug Monit. 27:655–665.
   PubMed Web of Science ®Google Scholar
• Shih TM, Duniho SM, McDonough JH. 2003. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol Appl Pharmacol. 188:69–80.
   PubMed Web of Science ®Google Scholar
• Shih TM, Koviak TA, Capacio BR. 1991. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci Biobehav Rev. 15:349–362.
   PubMed Web of Science ®Google Scholar
• Shih TM, McDonough JH. Jr. 1997. Neurochemical mechanisms in soman-induced seizures. J Appl Toxicol. 17:255–264.
   PubMed Web of Science ®Google Scholar
• Shih TM, McDonough JH. Jr. 1999. Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment. Pharmacol Biochem Behav. 64:147–153.
   PubMed Web of Science ®Google Scholar
• Shih TM, McDonough JH, Koplovitz I. 1996. Evaluation of anticonvulsant drugs for soman-induced seizure activity. Int J Toxicol. 15:43–60.
   Google Scholar
• Shih TM, Rowland TC, McDonough JH. 2007. Anticonvulsants for nerve agent-induced seizures: the influence of the therapeutic dose of atropine. J Pharmacol Exp Ther. 320:154–161.
   PubMed Web of Science ®Google Scholar
• Shih TM, Skovira JW, O'Donnell JC. 2009. Central acetylcholinesterase reactivation by oximes improves survival and terminates seizures following nerve agent intoxication. Adv Studies Biol. 1:155–196.
   Google Scholar
• Sparenborg S, Brennecke LH, Jaax NK, Braitman DJ. 1992. Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology. 31:357–368.
   PubMed Web of Science ®Google Scholar
• Taylor P. 2011. Anticholinesterase agents. In: Brunton L, Chabner B, Knollman B, editors. Goodman & Gilman’s the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; pp. 239–254.
   Google Scholar
• Wang LY, Wang Y, Zheng JQ, Zhong BH, Liu H, Dong SJ, Ruan JX, Liu KL. 2005a. Pharmacological profiles of an anticholinergic agent, phencynonate hydrochloride, and its optical isomers. Acta Pharmacol Sin. 26:527–532.
   PubMed Web of Science ®Google Scholar
• Wang YA, Zhou WX, Li JX, Liu YQ, Yue YJ, Zheng JQ, Liu KL, Ruan JX. 2005b. Anticonvulsant effects of phencynonate hydrochloride and other anticholinergic drugs in soman poisoning: neurochemical mechanisms. Life Sci. 78:210–223.
   PubMed Web of Science ®Google Scholar
• Wetherell J, Hall T, Passingham S. 2002. Physostigmine and hyoscine improves protection against the lethal and incapacitating effects of nerve agent poisoning in the guinea-pig. Neurotoxicology. 23:341–349.
   PubMed Web of Science ®Google Scholar
• Wetherell JR. 1994. Continuous administration of low dose rates of physostigmine and hyoscine to guinea-pigs prevents the toxicity and reduces the incapacitation produced by soman poisoning. J Pharm Pharmacol. 46:1023–1028.
   PubMed Web of Science ®Google Scholar
• Wills JH. 1963. Pharmacological antagonists of the anticholinesterase agents. In: Eichler O, Farah A, editors. Handbuch der experimentellen pharmakologie. Berlin, Germany: Springer-Verlag; pp. 883–920.
   Google Scholar
• Xu GZ, Cai ZJ, Dong L, Huang CY, Liu WW, Zhao RB, An DY, Zu XR, Wang SF, Wang HB. 1993. Clinical study of phencynonate hydrochloride in the prevention of motion sickness. Chin J Clin Pharmacol. 9:65–74.
   Google Scholar